University of Birmingham

Other

Pipeline Programs↗

Distinct drugs in development (Preclinical–Phase 3)

Indications↗

Distinct diseases across all programs

Clinical Trials↗

All sponsored trials (all statuses)

Pipeline

Pipeline Snapshot

By Phase

4 drugs in development

Phase 31

Phase 22

Preclinical1

By Therapeutic Area

top 1

Oncology

360%

R&D Momentum

59/100

Pipeline Velocity

22/100

Trial Completion Rate

78/100

Pipeline Concentration

52/100

Pipeline Freshness

20/100

Activity

Recent Activity

Last 14 days

Oct 27, 2026

Recruiting

A Phase III, Randomised, Open-label, Multicenter International Trial Comparing Ruxolitinib With Either HydRoxycarbamIDe or Interferon Alpha as First Line ThErapy for High Risk Polycythemia Vera

Oct 23, 2026

Recruiting

Whey Protein Dose-response Effect on Daily Glycaemic Excursions in Very Old Individuals With Type 2 Diabetes

Earlier

Oct 17, 2026TrialA Randomised Controlled Phase II Trial of Temozolomide With or Without Cannabinoids in Patients With Recurrent Glioblastoma

Oct 8, 2026TrialAcute Effects of Dietary Flavanols on Microvascular Responses to Mental Stress in White European and South Asian Women: A Randomised, Placebo-controlled, Double-blind, Cross-over Preliminary Intervention Study

Sep 29, 2026TrialA Phase III, Multicentre, Double Blind, Placebo-Controlled, Randomised Clinical Trial of Apixaban THROMBOprophylaxiS TO Prevent Venous Thromboembolism in Ambulatory Lung Cancer Patients Undergoing Systemic Anticancer Treatment

Sep 25, 2026TrialFARGO: A Randomised, Phase IIa, Multi-centre, Placebo-controlled Trial of FAecal Microbiota Transplantation in primaRy sclerosinG chOlangitis

Aug 26, 2026TrialSurgWeek-2: Identifying the Global Burden of Post Operative Complications: an International Prospective Cohort Study Protocol

Aug 22, 2026TrialThe Effects of an Innovative Novel Bioactive Peptide Supplement on Skeletal Muscle Anabolism, Autophagy, and Adaptations to Long Term Full Body Resistance Exercise Training in Young Healthy Individuals

4 more events

Aug 20, 2026TrialUnderstanding the Effects of Obesity on Autophagic and mTORC1 Signalling Following Resistance Exercise and Protein Ingestion in Skeletal Muscle.

Aug 15, 2026TrialA Double-Blind, Phase III, Randomised Study to Compare the Efficacy and Safety of Oral Azacitidine (CC-486) Versus Placebo in Subjects With Acute Myeloid Leukaemia or Myelodysplastic Syndromes as Maintenance After Allogeneic Haematopoietic Stem Cell Transplantation

Aug 8, 2026TrialA Phase II, Randomised Study of CHOP-R in Combination With Acalabrutinib Compared to CHOP-R in Patients With Newly Diagnosed Richter's Syndrome and a Platform for Initial Investigations Into Activity of Novel Treatments in Relapsed/Refractory and Newly Diagnosed Richter's Syndrome.

Jun 30, 2026TrialInternational Randomised Phase III Clinical Trial in Children With Acute Myeloid Leukaemia - Incorporating an Embedded Dose Finding Study for Gemtuzumab Ozogamicin in Combination With Induction Chemotherapy

Details

Company Info

Company Overview

—

Mkt Cap

—

Revenue

—

Cash

Pipeline

Drug Pipeline

Indication

Preclinical

Phase 1

Phase 2

Phase 3

Approved

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)

University of Birmingham

Pipeline Snapshot

Recent Activity

Company Info

Drug Pipeline

Oncology

Unknown / Other

Oncology

Unknown / Other